Showing results (1671-1680 of 21,687) with videos related to
Sort By:
Pageof 2,169
Urology|March 1, 1997
Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladderR E Greenberg, R R Bahnson, D Wood, et al.Urology|March 1, 1997
Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancersC N Papandreou, T Bogenrieder, F Loganzo, et al.Urology|March 1, 1997
Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levelsM C Charlesworth, C Y Young, G G Klee, et al.Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.Urology|March 1, 1997
PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study GroupD G McLeod, C F Johnson, E Klein, et al.Urology|March 1, 1997
Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical resultsA L Zietman, E A Prince, B M Nakfoor, et al.Urology|October 1, 1979
Incidence of prostatic calcification in blacks in Washington, D.C., and selected African cities. Correlation of specimen roentgenographs and pathologic findings. Cooperative Prostatic Research GroupJ Kovi, M S Rao, M Y Heshmat, et al.Urology|April 1, 1997
Phase II studies on prostate cancerF H Schröder, U Norming, B A Blumenstein, et al.Urology|April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trialsR Hall, P O Hedlund, R Ackermann, et al.Pageof 2,169